首页> 外文OA文献 >The efficacy and safety of B-type natriuretic peptide (nesiritide) in patients with renal insufficiency and acutely decompensated congestive heart failure

【2h】

The efficacy and safety of B-type natriuretic peptide (nesiritide) in patients with renal insufficiency and acutely decompensated congestive heart failure

机译：B型利钠肽（Nesiritide）在肾功能不全和急性失代偿性充血性心力衰竭患者中的疗效和安全性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
J. Butler;
展开▼
作者单位

展开▼
年度 2004
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The efficacy and safety of B-type natriuretic peptide (nesiritide) in patients with renal insufficiency and acutely decompensated congestive heart failure. [J] . Butler J, Emerman C, Peacock WF, Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association . 2004,第2期

机译：B型利钠钠肽（奈西利肽）在肾功能不全和急性代偿性充血性心力衰竭患者中的疗效和安全性。
2. Predictors of worsening renal function in adult patients with congestive heart failure receiving recombinant human B-type brain natriuretic peptide (nesiritide) [J] . Jose Iglesias, Deborah Hom, Maria Antoniotti, Nephrology Dialysis Transplantation . 2006,第12期

机译：接受重组人B型脑利钠肽（奈西利肽）的成人充血性心力衰竭患者肾功能恶化的预测因子
3. Predictors of worsening renal function in adult patients with congestive heart failure receiving recombinant human B-type brain natriuretic peptide (nesiritide). [J] . Iglesias J, Hom D, Antoniotti M, Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association . 2006,第12期

机译：接受重组人B型脑利钠肽（奈西利肽）的充血性心力衰竭成年患者肾功能恶化的预测因子。
4. Clinical Efficacies of Recombinant Human Brain Natriuretic Peptide in the Treatment of Patients with Heart Failure Due to Valvular and Non-Valvular Heart Disease [C] . Jing Bai, Yan Wang 2019 International Conference on Biology, Chemistry and Medical Engineering（ 2019年国际生物、化学和医学工程会议（ICBCME 2019）论文集 . -1

机译：重组人脑利钠肽在瓣膜和非瓣膜心脏病患者治疗心力衰竭患者中的临床疗效
5. The development of an educational pre- and post-prescribing protocol for the use of nesiritide in acute decompensated heart failure through evidence -based medicine [D] . Kirkhart, Vincent R. 2006

机译：通过循证医学开发奈斯利肽在急性失代偿性心力衰竭中的处方前和处方后教育方案的开发
6. Evolution of B-type natriuretic peptide and N-terminal pro-brain natriuretic peptide during acute decompensated heart failure in a chronic heart failure patient with reduced ejection fraction treated with Sacubitril/Valsartan: a case report [O] . Ambre Tiepolo, Hélène Nougué, Charles Damoisel, 2019

机译：接受Sacubitril / Valsartan治疗的射血分数降低的慢性心力衰竭患者急性失代偿性心力衰竭期间B型利钠肽和N端脑钠肽的演变：病例报告
7. Effects of nesiritide (B-type natriuretic peptide) on pulmonary artery pressures in patients with acute decompensated congestive heart failure [O] . Young James B. 2002

机译：奈西立肽（B型利钠肽）对急性失代偿性充血性心力衰竭患者肺动脉压的影响

The efficacy and safety of B-type natriuretic peptide (nesiritide) in patients with renal insufficiency and acutely decompensated congestive heart failure

著录项

引文网络

相似文献

相关主题

期刊订阅